Cellectar

Cellectar

Cellectar

PDC Cancer Therapeutics and Diagnostics, Targeted Delivery of Oncologic Payloads, #MultipleMyeloma #ClinicalTrial #HemOnc
Raised
$13.6M
Follow us
Alexa global traffic share
Acquired by
Latest funding Show all
$617,500
Debt financing - 2014
Undisclosed amount
Post-IPO equity - 2011
Xconomy

Doyenne, Epic, Cellectar, & More: This Week’s Wisconsin Watchlist

Health
Xconomy

Cellectar Biosciences Shutting Down Manufacturing Operations

Manufacturing Health
Xconomy

Promega, Cellectar, Blockchain, & More: This Week’s WI Watchlist

Science Health
Xconomy

Gener8tor, Shine, Cellectar, & More: This Week’s Wisconsin Watchlist

Health
Xconomy

Epic, Zuckerberg, Cellectar, & More: This Week’s Wisconsin Watchlist

Health
Xconomy

WARF, Cellectar Expand Licensing Agreement For Blood Cancer Drug

Legal Health Science
Xconomy

After Navigating Ups and Downs, Cellectar CEO Caruso Looks to Future

Health
Xconomy

Cellectar Awarded Another Cancer Drug Patent

Health Legal
Xconomy

Cellectar Announces $8M Stock Offering, Sending Shares Lower

Earnings Stock markets